stride study semaglutide STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients Semaglutide in Peripheral Artery Disease:

Processed foods called out directly Highly processed foods are explicitly discouraged for the first time, especially those high in added sugars, refined carbs, and artificial ingredients

Because GLP-1 drugs frequently result in muscle mass and body fat loss, it is critical to compensate as much as possible by ingesting protein

It also influences insulin sensitivity and glucose metabolism, which are essential factors in weight management, especially for those with obesity-related health issues like type 2 diabetes

The Tirzepatide Injection Protocol from PlexusDx is a compounded GIP/GLP-1 dual agonist prescribed by licensed providers

Gastroenterology 123 : 11201128 Asakawa A et al

Additionally, educating patients about the importance of adequate protein intake, strength training, sleep, and stress management can contribute to a healthier and more successful weight loss journey